SURVEY OF THYROGLOBULIN CONCENTRATION IN PATIENTS WITH PAPILLARY THYROID CARCINOMA AFTER TOTAL THYROIDECTOMY

Phan Uyển Nhi Nguyễn 1, Xuân Cảnh Nguyễn 2, Nguyên Trung Võ 3,
1 Danang University of Medical Technology and Pharmacy
2 Cho Ray Hospital
3 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Objectives: This study aims to investigate serum Thyroglobulin (Tg) levels after total thyroidectomy and the relationship between serum Tg levels and thyroid cancer (TC) stages in patients with papillary thyroid carcinoma (PTC). Methods: Retrospective study of 160 papillary thyroid cancer patients after total thyroidectomy from 01/2023 to 07/2024 at Cho Ray Hospital. Results: The rate of women with PTC had 7,94 times higher than men. The stage of disease after total thyroidectomy with the highest rate is stage I (76.68%); 13.12% of patients have concomitant Hashimoto's thyroiditis (HT). Median serumTg levels decreased significantly (p<0,05), from 3,5 ng/mL after thyroidectomy to 0,14 ng/mL after radioactive Iodine treatment. In the group of patients with only PTC, serumTg levels was significantly higher (3,79 ng/mL) than in the group with PTC and Hashimoto's thyroiditis (0,69 ng/mL); this difference was statistically significant (p < 0.05). There was a weak positive correlation between lymph node and serumTg levels at postoperative with r = 0.2 and p < 0,05. Conclusion:  There was a weak positive correlation between lymph node and serumTg levels at postoperative. There is no association between serum Tg levels and the stages of papillary thyroid cancer after total thyroidectomy.

Article Details

References

1. GLOBOCAN. Cancer Today. 2020. 29/06/2023. https://gco.iarc.fr/today/home
2. Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocrine pathology. Mar 2022; 33(1): 27-63. doi:10.1007/s12022-022-09707-3
3. Bộ Y tế. Thông tư số 1514/QĐ-BYT ban hành ngày 01/04/2020 về tài liệu chuyên môn "Hướng dẫn chẩn đoán và điều trị một số bệnh ung bướu". Hà Nội: Nhà xuất bản Hà Nội; 2020.
4. Li S, Ren C, Gong Yea. The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer. Frontiers in endocrinology. 2022;13: 872527. doi:10.3389/fendo.2022.872527
5. Dương Thị Phượng và cộng sự. Đặc điểm lâm sàng, cận lâm sàng của người bệnh ung thư tuyến giáp sau phẫu thuật tại Bệnh viện Đại học Y Hà Nội. Tạp chí Nghiên cứu Y học. 2022;159(11):1-9.
6. Trần Thị Đ, Nguyễn Vinh Q, Nguyễn Ngọc H. Khảo sát một số đặc điểm lâm sàng, cận lâm sàng bệnh nhân ung thư tuyến giáp thể biệt hóa tại Bệnh viện Nội tiết Trung ương. 2021;(50):99-105. Tạp chí Nội tiết Đái Tháo Đường.
7. Battistella E, Pomba L, Costantini A, et al. Hashimoto's Thyroiditis and Papillary Cancer Thyroid Coexistence Exerts a Protective Effect: a Single Centre Experience. Indian journal of surgical oncology. Mar 2022;13(1):164-168. doi:10.1007/s13193-022-01515-9
8. Haugen BR, Alexander EK, Bible KCea. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid: official journal of the American Thyroid Association. Jan 2016;26(1):1-133. doi:10.1089/thy.2015.0020
9. Zheng K, Mao J. Comparison and Analysis of Clinical Features of Papillary Thyroid Cancer Complicated With Hashimoto's Thyroiditis. Clinical Medicine Insights Oncology. 2024;18: 11795549241287085. doi:10.1177/ 11795549241287085
10. Wang F, Nie H, Li W, et al. The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT/CT. BMC Medical Imaging. 2021/05/08 2021;21(1):78. doi:10. 1186/s12880-021-00612-5